Anifrolumab-containing medicinal products
Originaltitel der Bekanntmachung
Czechia – Immunosuppressive agents – Léčivé přípravky s obsahem anifrolumabu
Opportunity Score
Warum diese Bewertung?
Chance
55 / 100
Komplexität
67 / 100
Risikofaktoren
The procurement documents were not provided for analysis, so material requirements may be missing, including technical...
Supplies are based on the contracting authority's current needs, but quantities, demand forecasts, minimum commitments...
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Eckdaten der Ausschreibung
- Öffentlicher Auftraggeber
- Fakultní nemocnice Hradec Králové
- Land
- Tschechien
- CPV
- 33652300 - Immunosuppressive agents
- Frist
- Nov 10, 2026
- Geschätzter Wert
- CZK 9.1M (approx. EUR 372k)
Überblick
Moderate opportunityWichtige Fakten
- CZK 9.1M estimated value
- Supplies contract
- 1 lot
- Duration 4 YEAR
- Ongoing supply of medicinal products containing anifrolumab.
- Deliveries are to be made according to the contracting authority's current needs.
Vollständige Zusammenfassung anzeigen
Open procedure for four years of ongoing supplies of medicinal products containing anifrolumab, classified as immunosuppressive agents. The estimated value is CZK 9,064,670 and performance is in Czechia. Electronic submission is required and the stated language is Czech. Procurement documents are referenced but no extracted document text was provided, so key commercial, technical, eligibility, and submission details remain unverified.
Risiken
The procurement documents were not provided for analysis, so material requirements may be missing, including technical...
Supplies are based on the contracting authority's current needs, but quantities, demand forecasts, minimum commitments...
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- The procedure is an open procedure.
Administrative
- Electronic submission is required.
- The stated language is Czech.
Anforderungen können unvollständig sein.
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
Hradec Králové, CZE
Website
Auftraggeberprofil
Kennung
00179906
Tätigkeit
Health
Lose (1)
LOT-0001
Anifrolumab-containing medicinal products
The lot covers ongoing deliveries of medicinal products containing anifrolumab according to the contracting authority's current needs over a four-year period. Lot-specific quantities, product specifications, delivery arrangements, and value are not provided in the structured data.
EUR 372k
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
nejnižší celková nabídková cena v Kč bez DPH/4 roky.
Originale TED-Daten anzeigen
Originaler Los-Titel
Léčivé přípravky s obsahem anifrolumabu
Originale TED-Beschreibung
Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem anifrolumabu po dobu 4 let dle aktuálních potřeb zadavatele.
Vergabedetails
- Veröffentlichungsdatum
- 11 Oct 2026
- Sprachen
- Czech
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 700339-2026
Dokumente (1)
Opportunity Score
Warum diese Bewertung?
Chance
55 / 100
Komplexität
67 / 100
Risikofaktoren
The procurement documents were not provided for analysis, so material requirements may be missing, including technical...
Supplies are based on the contracting authority's current needs, but quantities, demand forecasts, minimum commitments...
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications